肝癌双介入治疗后血清铁蛋白变化与预后的关系研究

The Relationship Hepatic Carcinoma Double Interventional Treatment Serum Ferritin Levels and Prognosis

目的:为了分析经 TACE 联合RFA治疗后肝癌血清铁蛋白的水平与预后的关系。方法选取中晚期肝癌患者40例,非随机分为两组,A组采用 TACE+RAF治疗,B组采用静脉化疗或最佳姑息治疗,其中男性A组16,B组4例,女性A组12例,B组8例,中位年龄A组63岁,B组61岁。分别在治疗前,治疗后1月、3月测定血清铁蛋白,两组比较。结果 A/B组治疗后血清铁蛋白水平明显下降,但A组治疗后1月、3月的下降更明显。结论血清铁蛋白的水平高低变化与肝癌的进展或好转有相关性,治疗后血清铁蛋白下降越多的,预后越好。

Objective:to analyze the joint TACE and RFA liver cancer after treatment with conventional serum ferritin level and prognosis,the relationship between.Methods:40 patients with terminal-stage liver cancer,not randomly divided into two groups,group A conventional TACE+RAF therapy,group B,intravenous chemotherapy or best pal iative care,including male 16 group A,B group of four people,women,A group of 12 people,B group of eight people,median age group A 63-year-old,group B at the age of 61.Respectively,before treatment,1 month,3 months after treatment to determine serum ferritin,comparing the two groups.Results:A/B group of serum ferritin levels significantly decreased after treatment,but 1 month,3 months after treatment group A drop is more obvious.Conclusion:the serum ferritin level changes have correlation with the progress of the liver cancer or improved,after treatment serum ferritin declined more,the bet er the prognosis.